Recent in vitro and in vivo pre-clinical studies have demonstrated that COX-2 overexpression plays a key role in tumor resistance by stimulating epithelial cell proliferation and angiogenesis, increasing multidrug resistance, and enhancing cell motility and invasion [8,11,12,13,14]. The gene discussed is PTGS2; the disease is neoplasm.